Research Overview
CJC-1295/Ipamorelin combines two research peptides that act through distinct signaling systems associated with growth-hormone regulation. CJC-1295 is studied in relation to growth-hormone-releasing hormone (GHRH) receptor signaling, while ipamorelin is studied as a ghrelin-receptor/secretagogue ligand.
Research Areas of Interest
- GHRH-receptor signaling
- Ghrelin-receptor and secretagogue pathways
- Growth-hormone-axis research
- Combined receptor-signaling studies
Product Details
| Strength | 10mg |
|---|---|
| Category | Peptide & Endocrine Signaling |
For Research Use Only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Purchaser is responsible for compliance with applicable laws, regulations, and institutional policies.





Reviews
There are no reviews yet.